InJose @ VidalbyJosé @ Vidal·Jun 28Critical Thinking (IV): Spanish Health Policy, A Downpour of Regulations and LawsIn recent months, the Spanish Ministry of Health has launched one of the most ambitious regulatory agendas in recent years.
InJose @ VidalbyJosé @ Vidal·May 28Varda Space Industries and United Therapeutics: When Low Earth Orbit Starts Looking Like a Supply…This is not the first time we have exposed Varda Space Industries in this online portfolio. The first publication dates back to mid-2023…
InJose @ VidalbyJosé @ Vidal·Apr 29The Multiplier Effect of Compound Interest in Health (II)In October 2024, I wrote in this online portfolio about how compound interest not only transforms financial capital, but also our health…
InJose @ VidalbyJosé @ Vidal·Mar 31As for the results of the AMIE feasibility studyIn my monthly publication in April 2025, I have already devoted a few lines to analyze the research conducted by Google for Health in this…
InJose @ VidalbyJosé @ Vidal·Feb 28Price pressure and the minimum viable organizationEverything that happens in the United States eventually reaches Europe, even if it´s with some delay- an old continent in every sense. In…
InJose @ VidalbyJosé @ Vidal·Jan 31The lessons of KatyThis first post of 2026 may be one of the least professional I’ve published since I started sharing content back in 2013.
InJose @ VidalbyJosé @ Vidal·Nov 30, 2025On Joint Clinical Assessment (JCA) in EuropeA few weeks ago, Mia Malmenas and Xin Zhao published in Health Economics a rather simple and explicit article that highlights the…A response icon1A response icon1
InJose @ VidalbyJosé @ Vidal·Oct 30, 2025The Challenge of Health Data in Spain: Technology, Interoperability, and Public Trust
